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Abstract 
 
Bovine herpesvirus 1 (BoHV-1) and BoHV-5 are closely related (82% amino 
acid identity) but differ strongly in neuropathogenesis. The immediate-early 
gene for BICP0 is less conserved (70% amino acid identity) and may contribute 
to a dissimilar phenotype. A peculiar difference is a guanosine hexamer in the 
BICP0-1 gene which aligns with only five guanosines in the BICP0-5 gene and 
therefore results in a frameshift in the latter open reading frame. Thus, the C-
terminal amino acid sequence (residues 643-676 of BICP0-1 vs. 655-720 of 
BICP0-5) is completely different. We introduced the BICP0-5 frameshift into 
the BoHV-1 genome cloned as a bacterial artificial chromosome (BoHV-1 
BAC) using the Red recombination system with galK selection and 
counterselection. Transfection of MDBK cells with the resulting BAC produced 
recombinant virus that replicated like wild type BoHV-1 in vitro. Attempts to 
exchange the entire BICP0-1 gene by the BoHV-5 homolog using the same 
approach failed repeatedly. Therefore, we cotransfected purified BICP0-/galK+-
BoHV-1 BAC DNA with a recombination plasmid coding for BICP0-5 with or 
without a HA tag into MDBK cells. BoHV-1 recombinants expressing the 
respective proteins were characterized. In vitro, all recombinants grew to similar 
titers as the parental viruses, which demonstrates that BICP0-5 compensates for 
the growth defect of BICP0-/galK+-BoHV-1 and functionally complements 
BICP0-1 of BoHV-1. We conclude that BICP0 may be suitable to positively 
select BoHV-1 recombinants with deletions or insertions of additional genes of 
interest. 
 
Keywords: Bovine herpesvirus 1; bovine herpesvirus 5; immediate-early protein 
BICP0; bacterial artificial chromosome; Red recombination; recombinant virus 
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1. Introduction 
Bovine herpesvirus 1 (BoHV-1) and BoHV-5 are two closely related members 
of the subfamily Alphaherpesvirinae. The sequences of both viral genomes have 
been published (BoHV-1: AJ00480.1, BoHV-5: NC_005261.1). The 
approximately 70 genes are arranged in a colinear fashion, and the encoded 
proteins show 82% amino acid sequence identity on average (Delhon et al., 2003; 
Schwyzer and Ackermann, 1996). Nevertheless, the viruses exhibit a different 
pathogenicity: BoHV-5 is strongly neuropathogenic in young calves (Meyer et al., 
2001), rabbits (Meyer et al., 1996) and immunodeficient mice (Abril et al., 2004), 
where infection leads to fatal encephalitis. Although BoHV-1 is also a 
neurotropic pathogen, it is usually unable to invade the central nervous system 
(CNS) and cause neurological disease to any significant degree (Muylkens et al., 
2007). The molecular basis for the different neuropathogenicity of the two 
viruses is known only in part (Del Medico Zajac et al., 2009a). Glycoprotein E (gE) 
and the tegument protein US9 are thought to play a role in neurovirulence (Al-
Mubarak and Chowdhury, 2004; Chowdhury et al., 2000; Chowdhury et al., 2002). 
During the lytic infection cycle, the genes of both viruses are expressed in three 
temporal phases termed immediate early (IE), early and late. Three major IE 
proteins, named BICP0, BICP4, and BICP22, regulate these phases by either 
transactivating or transrepressing specific virus genes. The IE proteins interact 
as multifunctional units with specific host cell proteins (Jones and Chowdhury, 
2007; Saydam et al., 2004; Saydam et al., 2006). 
Both viruses establish latency in sensory neurons, where their genomes persist 
for the host's lifetime, awaiting reactivation into a new lytic cycle. During 
latency of BoHV-1 in trigeminal ganglia, only the latency related (LR) 
transcripts that overlap a large part of the BICP0 gene in the opposite direction, 
and the ORF-E transcripts, which are transcribed just downstream from BICP0 
in the same direction, are detectable. LR and ORF-E gene products promote 
establishment and maintenance of latency; BICP0 promotes the reactivation 
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cycle (Jones and Chowdhury, 2007). In BoHV-5, however, equivalents of LR and 
ORF-E have not been detected, nor can their features be recognized in the 
sequence. Counterparts of BICP0, named BICP0-1 and BICP0-5, do exist but 
are only moderately conserved (70% amino acid identity), which may contribute 
to the divergent phenotype. Towards clarification of this assumption and 
assisted by BAC technology, we generated recombinant BoHV-1, in which the 
BICP0-1 gene was replaced by genes encoding variants of BICP0-5. Here we 
show that BICP0-5 functionally complements BICP0-1. 
 
2. Material and methods 
2.1. Cell culture and virus 
Madin Darby bovine kidney (MDBK) and human osteosarcoma U2OS cells 
were cultured in Dulbecco’s modified Eagle’s medium (DMEM) supplemented 
with 10% fetal bovine serum, 100 U/ml penicillin and 100 µg/ml streptomycin 
in 5% CO2 at 37°C. Wild type (wt) BoHV-1 strain Jura, wt BoHV-5 strain N569 
and recombinant viruses were propagated in MDBK cells. 
2.2. Red recombination for frameshift insertion 
The parent BAC, originally designated f115.003 (Wild et al., 2005), and here 
renamed f115(DF), contains the complete genome of BoHV-1 strain Jura in the 
prototype orientation characterized by HindIII D and F fragments (Schwyzer and 
Ackermann, 1996). In this BAC, the pBeloBAC11 sequence required for 
propagation in bacteria, adjacent to the eGFP gene under control of the hCMV 
IE promoter, has been inserted with flanking loxP sites between the BoHV-1 
circ and BICP27 loci (Tobler et al., 2002). The protocol for Red recombination in 
E. coli strain SW102 was applied according to published procedures (de Oliveira 
et al., 2008; Warming et al., 2005). Briefly, in a first step, a DNA fragment 
containing the galK expression cassette flanked by 50-bp homology arms 
targeting the BoHV-5 specific frameshift (Fig. 1A) was electroporated into 
SW102 bacteria harboring the f115(DF) BAC, and recombinant BAC clones 
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were selected on galactose minimal medium plates. The resulting f115-2-galK 
BAC, in which the BICP0 gene is disrupted, was targeted in a second step by 
double stranded oligonucleotides to restore BICP0 and to generate a mutant 
BAC containing the BoHV-5 specific frameshift (f115-B5) and a revertant BAC 
(f115-K1). 
Step 1. The galK cassette with suitable homologous ends for the frameshift 
insertion was generated by PCR on the pgalK plasmid using 1 pmol each of 
primer fs57 and primer fs58 (Table 1). The reaction was performed using 
Phusion polymerase (F-530-S, Finnzymes) with an initial denaturation step at 
98°C for 60 sec followed by 35 cycles of 98°C for 30 sec, annealing at 60°C for 
30 sec and elongation for 45 sec at 72°C. The resulting fragment was purified 
after 1% agarose gel by QiaexII extraction as recommended by the manufacturer 
(Qiagen) and used for electroporation. 
Correct insertion of the galK cassette in the f115-2-galK BAC was checked by 
AsuII cleavage and by PCR (Fig. 2), using primer pairs fs_seq_7 and fs38; fs33 
and fs34; fs37 and o2 (Table 1). These reactions were performed using Taq-
Beads (Amersham) in 25 µl containing 1 pmol of the appropriate primer pair, 
0.1 µg of template DNA and 1 M betain, with denaturation at 95°C for 3 min, 
followed by 35 cycles at 95°C for 1 min, 56°C for 30 sec, and 72°C for 1 min. 
The fragments were analyzed on a 2% agarose gel. 
Step 2. The cassette in the f115-2-galK BAC was exchanged by electroporation 
of the annealed oligos fs59 and fs60 (Table 1) into electrocompetent and 
recombinase-induced SW102 cells using counterselection on DOG plates to 
create the frameshift mutant f115-B5 BAC. To create the revertant f115-K1 
BAC, the galK cassette in f115-2-galK was replaced by the annealed oligos fs61 
and fs62 in a similar fashion. 
2.3. Red recombination for replacement of the BICP0-1 ORF 
The galK cassette targeting the entire BICP0-1 ORF was generated by PCR on 
the pgalK plasmid using 1 pmol each of primer fs55 and primer fs56 (Table 1). 
6 
The reaction was performed using Phusion polymerase, and the isolated 
fragment was used to generate the f115-d0-galK BAC, which was characterized 
as above. 
2.4. Construction of transfer plasmids 
Cloning of the BICP0-5 ORF in pBSKS+ has been described (Zumsteg, 2006). 
The resulting plasmid pBSKS+BICP0-5 contains the entire BICP0-5 ORF 
flanked by PCR-generated restriction sites, a KpnI site upstream and a BamHI 
site downstream. The BamHI site replaces the stop codon because 
pBSKS+BICP0-5 was designed for constructing fusion proteins (Zumsteg et al., 
2006). The BoHV-1 homology arms extending 960 bp upstream and 970 bp 
downstream from the BICP0-1 ORF boundary were joined to pBSKS+BICP0-5 
as follows. (1) The downstream arm was generated from a BoHV-1 template by 
PCR using primers fs69 and fs70 (Table 1). The product was cleaved with 
BamHI and SpeI and inserted into pBSKS+BICP0-5 to give pBICP0-5-down. 
(2) pBHPJ6 containing BoHV-1 sequence 99'700-106'500 (Wirth et al., 1991) was 
cut with AvrII and Asp718I, then after filling overhanging ends with T4 DNA 
polymerase religated to give pBHAKJ4 containing the upstream arm. (3) 
pBICP0-5-down and pBHAKJ4 were both cut with BstXI to generate 3'-
overhanging ends that match only in the correct way because of the recognition 
sequence CCAnnnnn/nTGG. The 3140-bp fragment containing the BICP0-5 
ORF and the downstream arm from pBICP0-5-down was ligated with the 3830-
bp fragment containing the upstream arm and the pBSKS+ vector from 
pBHAKJ4 to give the desired transfer plasmid pBICP0-5-transf, which contains 
the BICP0-5 ORF with two extra C-terminal codons (glycine-serine) from the 
BamHI site, flanked by BoHV-1 homology arms. 
To add the HA tag, oligonucleotides HATag1 and HATag2 (Table 1) were 
annealed, cleaved with BamHI and inserted into the BamHI site of pBICP0-5-
transf, producing pBICP0-5-HA in two orientations. The correct orientation was 
identified by cleavage with AflII and nearby restriction sites. 
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2.5. Transfection of mammalian cells and virus rescue 
In a 24-well plate, each well was seeded with 105 U2OS or MDBK cells and one 
day later transfected with 1 µg of f115-B5 or f115-K1 BAC DNA using 
Lipofectamine2000 (Invitrogen). To remove the bacterial sequences of the BAC, 
0.05 µg of a Cre recombinase expressing plasmid (p116) was cotransfected (de 
Oliveira et al., 2008). One day after transfection of the BAC DNA, cells were 
examined in a Zeiss Axiovert S 100 fluorescence microscope. Virus was 
harvested 1-3 days after transfection. To rescue virus by homologous 
recombination with transfer plasmids encoding BICP0-5 (Fig. 1B), six-well 
plates were seeded with 5x105 MDBK cells and one day later cotransfected with 
f115-d0-galK BAC (1-2 µg) and pBICP0-5-transf or pBICP0-5-HA (both in the 
range of 0.2 to 2 µg) using Lipofectamine2000 as above. 
2.6. Circular virus DNA for electroporation into bacteria and BAC 
regeneration. 
In 6-cm plates, MDBK cells were infected with rf115-BICP0-5 or rf115-BICP0-
5-HA (m.o.i. = 5). After 4 h, cells were washed twice with PBS, then scraped 
with 0.7ml of 10mM EDTA, 10mM Tris-HCl, pH 8.0 into a tube. After addition 
of SDS to 0.6% and proteinase K to 0.25g/l, the resulting extract (Gabev et al., 
2009) was kept on ice (<1 h); aliquots (1-3 µl) were used for electroporation of 
E. coli strain DH10 as above, and colonies were isolated on chloramphenicol 
plates. 
 
3. Results 
3.1. Introduction of a BoHV-5-specific frameshift mutation into the BoHV-1 
BAC using Red recombination 
Comparison of the complete genome sequences of BoHV-1 and BoHV-5 shows 
that the immediate-early gene for BICP0 is among the least conserved genes 
(70% amino acid identity vs. 82% overall) and may contribute to a dissimilar 
phenotype. The most salient difference between BICP0-1 and BICP0-5 is in the 
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C-terminal region due to a cluster of six guanosines in the BICP0-1 gene which 
aligns with only five guanosines in the BICP0-5 gene. This frameshift leads to 
an alternative stop codon further downstream and results in a completely 
different C-terminal amino acid sequence (residues 643-676 of BICP0-1 vs. 
655-720 of BICP0-5).  
To investigate the effect of the BoHV-5 specific frameshift mutation in the 
context of the BoHV-1 genome, we used the Red recombination strategy with 
galK selection and counterselection (de Oliveira et al., 2008). In the first step, the 
PCR-amplified galK cassette was inserted by homologous Red recombination 
into the parent f115(DF) BAC in place of a single guanosine at position 1924 in 
the BICP0-1 ORF (Fig. 1A). Positive selection on galactose minimal medium 
plates yielded the f115-2-galK BAC, in which the BICP0 gene is disrupted. 
Successful integration of the galK cassette was confirmed by PCR (Fig. 2). In 
the second step, the galK cassette was replaced with the desired target sequence 
using counterselection on 2-deoxy-galactose (DOG) plates. The resulting mutant 
and the corresponding revertant, generated accordingly, were named f115-B5 
BAC and f115-K1 BAC, respectively. Both recombinants were marked with a 
translationally silent point mutation to provide a diagnostic restriction enzyme 
cleavage site (AvrII for f115-B5 and KpnI for f115-K1). Fig. 3 shows KpnI/SpeI 
restriction enzyme fragments of BAC DNA from eleven clones separated by 
field inversion gel electrophoresis (FIGE), eight of which exhibited the expected 
bands for f115-K1, notably the 14'422-bp and 4'969-bp bands resulting from the 
diagnostic KpnI site in the 19'391-bp fragment of the parent BAC. The 
remaining clones were unexpected: one probably corresponded to input f115-2-
galK (Fig. 3, lane 11), one to parent f115(DF) (Fig. 3, lane 6), and one presented 
an unexplained hypermolar band of about 12'800 bp (Fig. 3, lane 9). In the same 
way, clones of f115-B5 BAC were identified using restriction enzymes AvrII 
and AflII for analysis (not shown). 
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To rescue recombinant viruses, BAC DNA was transfected into MDBK cells as 
well as into human U2OS cells. The latter were included in this experiment with 
regard to our earlier report (Steiner et al., 2006) that BICP0-1 interacts with p53, a 
protein which is produced at high levels in U2OS cells. Virus plaques appeared 
24 hours later (Fig. 4), shown as wide field images (top) and fluorescence 
microscopy images of the same field (bottom). Fluorescence due to eGFP 
encoded by the recombinants (Fig. 4, panels a to c) was no longer detectable 
after cotransfection of f115-B5 BAC DNA with the Cre recombinase expressing 
plasmid p116 in an equimolar ratio (Fig. 4d). Recombinant BoHV-1 was 
isolated from transfected MDBK cells, plaque purified, and designated rf115-
K1, rf115-B5 (both containing the F plasmid), and r115-B5 (lacking the F 
plasmid).  
Growth of recombinant and revertant BoHV-1 in MDBK cells was examined at 
low and high multiplicity of infection (0.01 and 5 m.o.i.). Compared with wild 
type BoHV-1 (Jura), rf115-B5 and r115-B5 replicated with equal efficiency, as 
did the revertant rf115-K1, all reaching titers of 108 TCID50/ml with similar 
kinetics (data not shown). Thus, neither the BoHV-5 specific C-terminal region 
of BICP0 nor the presence of the F plasmid did influence the course of lytic 
infection. 
3.2. Classical recombination of the BoHV-1 BAC in MDBK cells to replace the 
entire BICP0-1 gene by the BICP0-5 gene 
Attempts to replace the entire BICP0-1 gene by the BoHV-5 homolog in the 
BICP0-negative BoHV-1 BAC f115-d0-galK, which was obtained without 
difficulties by Red recombination, failed repeatedly. Taking into account that, 
although BICP0 is not strictly essential for lytic infection of BoHV-1, BICP0 
null mutants grow to at least 100-fold reduced titers because they lack the 
transactivation function of that IE protein (Geiser et al., 2005; Köppel et al., 1996), 
cotransfection of MDBK cells with the BICP0-negative f115-d0-galK BAC and 
a transfer plasmid containing the BICP0-5 gene and appropriate 1-kb flanking 
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sequences would restore the transactivation function and provide a strong 
selective advantage to viruses having inserted the BICP0-5 gene by classical 
homologous recombination (Fig. 1B). 
The transfer plasmid constructed for this purpose (pBICP0-5-transf) contains the 
entire BICP0-5 ORF including the stop codon, flanked by homologous BoHV-1 
sequences extending 960 bp upstream and 970 bp downstream from the BICP0-
1 ORF. As expected, after cotransfection of MDBK cells with f115-d0-galK and 
pBICP0-5-transf, virus plaques developed within two or three days. They 
exhibited eGFP fluorescence when the cotransfection was performed in the 
absence of p116, and no fluorescence when Cre recombinase was provided by 
p116 to cut out the bacterial F plasmid. From the resulting recombinant viruses, 
designated rf115-BICP0-5 and r115-BICP0-5, DNA was isolated and 
characterized by EcoRI, BamHI and AflII restriction enzyme analysis, FIGE and 
Southern blotting using a BICP0-5 probe (Fig. 5A, lanes 1 to 6). All patterns 
corresponded to the prediction from the sequence. To show that BACs can be 
regenerated from rf115-BICP0-5, circular virus DNA was extracted (Gabev et al., 
2009), electroporated into E. coli DH10, and the resulting BAC DNA was 
analyzed. Cleavage with BamH1 (Fig. 5A) revealed the two isomers: the 
prototype orientation (lane 10), and the US-inversion (lane 9).  
Since available antisera directed against BICP0-1 (Fraefel et al., 1994) were barely 
able to detect BICP0-5 in Western blots or by indirect immunofluorescence, a 
further transfer plasmid designated pBICP0-5-HA was constructed which 
contains the codons for a synthetic influenza hemagglutinin (HA) tag and a 
silent diagnostic AflII site fused in frame to the 3'-end of the BICP0-5 coding 
sequence. Upon cotransfection as described above, the viruses named rf115-
BICP0-5-HA and r115-BICP0-5-HA were isolated whose genomic DNAs 
displayed the predicted restriction enzyme cleavage patterns, including the 
altered AflII pattern resulting from the diagnostic site (Fig. 5A, lanes 7, 8). In 
Western blots, the HA-tagged BICP0-5 migrated with an apparent Mr of about 
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105 kDa (Fig. 5B) which is slightly larger than the 97 kDa observed for wt 
BICP0-1 (Fraefel et al., 1994) and seems consistent with the difference in length 
(731 vs. 676 amino acids). 
3.3. Growth kinetics of recombinant BoHV-1 
Growth characteristics in MDBK cells of r115-BICP0-5, r115-BICP0-5-HA, wt 
BoHV-1 strain Jura, and wt BoHV-5 strain N569 were compared after infection 
of cells at an m.o.i. of 0.01 and 5 (Fig. 6). Titers of virus released into cell 
culture supernatants and titers of virus remaining associated with cell pellets 
were determined separately. At low m.o.i., all four viruses reached similar titers 
of about 108.5 TCID50/ml in the supernatant (Fig. 6A) and 107 TCID50/ml in the 
pellet (Fig. 6B). The kinetics were not significantly different, except for the 
comparison between wt BoHV-1 and r115-BICP0-5, where the latter produced 
considerably higher titers (>1 log) at 24 h and 48 h, suggesting a slight growth 
advantage. At high m.o.i., r115-BICP0-5 was released into the supernatant 
clearly faster than the other three viruses (Fig. 6C), whereas all other 
comparisons revealed no significant differences (Fig. 6C and 6D). 
Taken together, these results demonstrate unequivocally that BICP0 encoded by 
BoHV-5 can fully functionally complement the replication defect caused by 
deletion of the homologous gene from the BoHV-1 genome. 
 
4. Discussion 
The Red recombination strategy with galK selection and counterselection 
permits efficient introduction of mutations into BACs (Warming et al., 2005) and 
has also been used before in our laboratory (de Oliveira et al., 2008). During the 
work described here, we experienced unexpected difficulties with this strategy 
when the entire BICP0-5 gene was used for insertion into the f115-d0-galK 
BAC. Among the resulting BACs we observed a great variety of restriction 
enzyme patterns. Most of them were not as expected, a few initially correct but 
genetically unstable. In the BICP0 locus, galK appears to be prone to 
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elimination by undesired recombination events. Recently, analysis of many 
intertypic recombinants between two strains of BoHV-1 has demonstrated that 
the recombination frequency is unequally distributed over the BoHV-1 genome, 
and highest in the US region as well as between US and the BICP0 locus 
(Muylkens et al., 2009). Similarly, intertypic recombination between BoHV-1 and 
BoHV-5 was shown to be favored by stretches of very high GC content (>90%) 
and to occur between very short (38 and 44 bp) segments of perfect sequence 
homology (Del Medico Zajac et al., 2009b). We assume that the BICP0 locus is a 
hotspot of legitimate or illegitimate recombination also in bacteria which, 
however, needs to be verified. 
We therefore exploited the transactivation function of BICP0, a major IE protein 
of BoHV-1 and BoHV-5 which is not essential but beneficial for BoHV 
replication in cell culture. The alternative strategy presented here (Fig. 1B) used 
classical homologous recombination in mammalian cells and positive selection 
for BICP0-5 expressing recombinants. Using transfer plasmids containing the 
gene encoding wt or HA-tagged BICP0-5 flanked by about 1-kb segments for 
homologous recombination, the desired recombinant viruses were generated 
within 2-3 days after cotransfection of f115-d0-galK BAC DNA and the 
respective recombination plasmids into MDBK cells. This approach proved to 
be versatile, which was demonstrated by isolation of additional recombinant 
viruses (rf115-BICP0-5-mRFP and rf115-dLR-BICP0-5-mRFP) described 
elsewhere (Steiner et al., 2009) (Vogt, B., Schraner, E., Steiner, F., Ackermann, 
M., Wild. P., and Schwyzer, M., unpublished). All these viruses contain the 
BoHV-1 backbone, in which BICP0-1 is the only gene replaced by BICP0-5 or 
its derivatives. In vitro, all recombinants replicate at least as efficiently as wt 
BoHV-1 or even approach the more efficient wt BoHV-5 (Fig. 6), enabling now 
in vivo studies of neuropathogenesis and latency. 
In summary, our results show that BICP0-5 can be tagged at the carboxy-
terminus of the protein and that wt and HA-tagged BICP0-5 can fully 
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complement the BICP0-1 function for BoHV-1 growth in vitro. We further 
demonstrate that BICP0-5 can be used to improve isolation of BoHV-1 
recombinants generated in a BICP0-negative genomic background, an approach 
that uses a regulatory active protein which, to the best of our knowledge, has not 
been described for alphaherpesviruses before. 
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Figure Legends 
Fig. 1. Strategies for generation of recombinant BoHV-1. (A) The parent BAC, 
f115(DF), contains the entire BoHV-1 genome (top) including the BICP0-1 gene 
(arrow). To generate f115-2-galK, a single guanosine at position 1924 near the 
end of the BICP0-1 gene was replaced by a galK cassette using Red 
recombination with a PCR product flanked by 50-nt homology arms. In the 
second step, the mutant f115-B5 BAC (five guanosines; BoHV-5 like) and, 
alternatively, the revertant f115-K1 BAC (six guanosines; BoHV-1 like) were 
generated using Red recombination. (B) To generate f115-d0-galK, the entire 
BICP0-1 gene was replaced by a galK cassette using Red recombination in 
bacteria as above. In the second step, classical recombination in eukaryotic cells 
was used for direct generation of recombinant viruses r115-BICP0-5 or r115-
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BICP0-5-HA upon cotransfection of f115-d0-galK with a transfer plasmid 
containing the BICP0-5 gene and appropriate 1-kb flanking sequences. 
 
Fig. 2. Presence of galK cassette in f115-2-galK verified by PCR. The PCR 
products 1, 2 and 3, obtained using the indicated primers (see scheme on the 
right and the Material and Methods section for details) were analyzed in a 2% 
agarose gel. M: 100-bp ladder. 
 
Fig. 3. Restriction enzyme analysis of f115-K1 DNA from clones obtained after 
Red recombination. BAC DNA was isolated from eleven clones, cleaved with 
KpnI and SpeI, and analyzed by FIGE at 4°C in a 0.7% agarose gel. Fragments 
of 14'422 bp and 4'969 bp resulting from the diagnostic KpnI site in f115-K1 
DNA (lanes 1-5, 7, 8 and 10) are indicated by arrows. Circles and square: 
19'391-bp and 20'621-bp fragments expected from parent f115(DF) and f115-
d0-galK, respectively. Triangle: hypermolar band (see text). M1: high MW 
lambda DNA markers; M2: 1-kb DNA ladder (both from Invitrogen). 
 
Fig. 4. Rescue of recombinant viruses from BAC DNA. U2OS (a, b) or MDBK 
cells (c, d) were transfected with 1 µg of f115-B5 DNA (a, c, d) or f115-K1 
DNA (b) in the presence (d) or absence of Cre recombinase. One day later, virus 
plaques were observed by wide field (top) and fluorescence microscopy 
(bottom). 
 
Fig. 5. (A) Restriction enzyme and Southern blot analysis of rf115-BICP0-5 (1 
to 6) and rf115-BICP0-5-HA (7, 8). Virion DNA was cleaved with EcoRI (1), 
BamHI (3), or AflII (5, 7); the bands were separated by FIGE as in Fig. 3, and 
then the bands corresponding to the BICP0-5 region (predicted sizes in bp are 
indicated) were revealed by Southern blot (2, 4, 6, 8) using as probe a 338-bp 
PCR product primed by o1 and o2 (Köppel et al., 1996). From rf115-BICP0-5, 
15 
BACs could be regenerated in bacteria; their DNA cleaved with BamHI 
revealed two orientations (9, 10). (B) Western blot of proteins from BICP0-5-
HA infected cells. The position of the 105-kDa BICP0-5-HA fusion protein 
recognized by rabbit polyclonal anti-HA-antibody is indicated. 
 
Fig. 6. Replication of recombinants r115-BICP0-5 and r115-BICP0-5-HA 
versus wild type BoHV-1 and BoHV-5. MDBK cells were infected with the 
different viruses at low multiplicity (A, B: moi = 0.01) and high multiplicity (C, 
D: moi = 5). Cell-free virus (A, C) and cell-associated virus (B, D) was titrated 
at the times indicated by limiting dilution (TCID50) in triplicate as described 
earlier (Köppel et al., 1996). 
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 Table 1. Oligonucleotide primers 
Name Sequencea 
fs57 GGCCCTGGCGACCGCCTGGCTGCGGCGCCAGGGCCGC
GCTGCTGCGGCGGCCTGTTGACAATTAATCATCGGCA 
fs58 CACCGAAATGGAAGTGGCCGCCTGGGTGCGAGAAAG
CCTCCTGGGGACCCTCAGCACTGTCCTGCTCCTT 
fs_seq_7 GCGGCTCGAAAGTTAAG 
fs38 ATGTTTCACCACGCCACGAAC 
fs33 TCGGCATAGTATAATACGACA 
fs34 GATCCCGCAGTTACAG 
fs37 GTTCGTGGCGTGGTGAAACAT 
o2 CGAGAGCTCGGCGCAGAAGA 
fs59 GGCCCTGGCGACCGCCTGGCTGCGGCGCCAGGGCCGC
GCTGCTGCGGCGGGGGTCCCTAGGAGGCTTTCTCGCA
CCCAGGCGGCCACTTCCATTTCGGTG 
fs60 CACCGAAATGGAAGTGGCCGCCTGGGTGCGAGAAAG
CCTCCTAGGGACCCCCGCCGCAGCAGCGCGGCCCTGG
CGCCGCAGCCAGGCGGTCGCCAGGGCC 
fs61 GCCCTGGCGACCGCCTGGCTGCGGCGCCAGGGCCGCG
CTGCTGCGGCGGGGGGTACCCAGGAGGCTTTCTCGCA
CCCAGGCGGCCACTTCCATTTCGGTG 
18 
fs62 CACCGAAATGGAAGTGGCCGCCTGGGTGCGAGAAAG
CCTCCTGGGTACCCCCCGCCGCAGCAGCGCGGCCCTG
GCGCCGCAGCCAGGCGGTCGCCAGGGC 
fs55 CATAAAAGCCCCGCGCATGCGCGAGCAGTTACTTTCG
GTTTGGGGATGACCCTGTTGACAATTAATCATCGGCA 
fs56 CGCTCCCGGCGCGTCACCCCGAGACGCGCGTATATAG
CGGCGCCCGGTCTTCAGCACTGTCCTGCTCCTT 
fs69 GGCGGATCCTAATCGCCGCGGCCGGCTC 
fs70 GCGACTAGTGGGCTGCAGTCCGGCGGAA 
HATag1 GATCCTATCCATATGATGTTCCAGATTATGCTTAAG 
HATag2 GATCCTTAAGCATAAT CTGGAACATCATATGGATAG 
a GalK sequence parts are in italics. 
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